Cargando…

The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature

Apatinib is a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor-2, which has been proved to be effective and safe in treating heavily pretreated patients with gastric cancer. The aim of the study was to explore the use of apatinib in treatment of nonsmall cell lun...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Lin, Li, Qing-Jian, You, Kai-Yun, Jiang, Zhi-Min, Yao, He-Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902403/
https://www.ncbi.nlm.nih.gov/pubmed/27196461
http://dx.doi.org/10.1097/MD.0000000000003598